Stay updated on Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.

Latest updates to the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe revision label in the page footer was updated from v3.5.3 to v3.5.4, indicating a new version of the study record history.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe revision in the record history advances from v3.5.2 to v3.5.3, representing a minor update to the page's revision history.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded revision v3.5.2 to the Record History and removed revision v3.5.0.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision history updated to add version v3.4.3 and remove version v3.4.2.SummaryDifference0.1%

- Check108 days agoChange DetectedA new revision entry v3.4.2 was added to the record history. The funding status notice and the earlier revision (v3.4.1) were removed.SummaryDifference0.8%

Stay in the know with updates to Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.